Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Grabner

Showing results (21-30 of 86) with videos related to

Pageof 9
Sort By:
Clinical Therapeutics|September 30, 2011
The value of atorvastatin over the product life cycle in the United StatesMichael Grabner, Wallace Johnson, Abdulla M Abdulhalim, et al.
Risk Management and Healthcare Policy|November 24, 2016
The SWEET SPOTS study: a real-world interpretation of the 2012 American Diabetes Association Position Statement regarding individualized A1C targetsNella Bieszk, Michael Grabner, Wenhui Wei, et al.
Postgraduate Medicine|June 11, 2013
Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vialMichael Grabner, James Chu, Swetha Raparla, et al.
The Journal of Sexual Medicine|December 13, 2016
Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured PopulationMichael Grabner, Amit Bodhani, Nikhil Khandelwal, et al.
Journal of Psychosomatic Research|May 24, 2016
Covariates of depression and high utilizers of healthcare: Impact on resource use and costsRebecca L Robinson, Michael Grabner, Swetha Rao Palli, et al.
Clinical Therapeutics|May 26, 2022
Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United StatesMeredith Hoog, Joseph L Smith, Maria Yu, et al.
Tree Physiology|October 12, 2018
The potential of Mid-Infrared spectroscopy for prediction of wood density and vulnerability to embolism in woody angiospermsTadeja Savi, Johannes Tintner, Luca Da Sois, et al.
Journal of Managed Care & Specialty Pharmacy|June 5, 2023
Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United StatesLia N Pizzicato, Richard Z Xie, Yiling Yang, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 25, 2026
Characteristics and Utilization Patterns of Medicare Beneficiaries Initiating Long-Acting Injectable Antipsychotic MedicationsMichael Grabner, Yueh-Yi Chiang, Chia-Chen Teng, et al.
The New Phytologist|February 3, 2022
Metabolism is a major driver of hydrogen isotope fractionation recorded in tree-ring glucose of Pinus nigraThomas Wieloch, Michael Grabner, Angela Augusti, et al.
Pageof 9

Showing results (21-30 of 86) with videos related to

Sort By:
Pageof 9
Clinical Therapeutics|September 30, 2011
The value of atorvastatin over the product life cycle in the United StatesMichael Grabner, Wallace Johnson, Abdulla M Abdulhalim, et al.
Risk Management and Healthcare Policy|November 24, 2016
The SWEET SPOTS study: a real-world interpretation of the 2012 American Diabetes Association Position Statement regarding individualized A1C targetsNella Bieszk, Michael Grabner, Wenhui Wei, et al.
Postgraduate Medicine|June 11, 2013
Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vialMichael Grabner, James Chu, Swetha Raparla, et al.
The Journal of Sexual Medicine|December 13, 2016
Clinical Characteristics, Health Care Utilization and Costs Among Men with Primary or Secondary Hypogonadism in a US Commercially Insured PopulationMichael Grabner, Amit Bodhani, Nikhil Khandelwal, et al.
Journal of Psychosomatic Research|May 24, 2016
Covariates of depression and high utilizers of healthcare: Impact on resource use and costsRebecca L Robinson, Michael Grabner, Swetha Rao Palli, et al.
Clinical Therapeutics|May 26, 2022
Association of Dulaglutide Initiation Timing With Treatment Patterns and Clinical Outcomes in Patients With Type 2 Diabetes Mellitus in the United StatesMeredith Hoog, Joseph L Smith, Maria Yu, et al.
Tree Physiology|October 12, 2018
The potential of Mid-Infrared spectroscopy for prediction of wood density and vulnerability to embolism in woody angiospermsTadeja Savi, Johannes Tintner, Luca Da Sois, et al.
Journal of Managed Care & Specialty Pharmacy|June 5, 2023
Real-world treatment modalities, health care resource utilization, and costs among commercially insured patients with newly diagnosed major depressive disorder in the United StatesLia N Pizzicato, Richard Z Xie, Yiling Yang, et al.
Clinicoeconomics and Outcomes Research : CEOR|February 25, 2026
Characteristics and Utilization Patterns of Medicare Beneficiaries Initiating Long-Acting Injectable Antipsychotic MedicationsMichael Grabner, Yueh-Yi Chiang, Chia-Chen Teng, et al.
The New Phytologist|February 3, 2022
Metabolism is a major driver of hydrogen isotope fractionation recorded in tree-ring glucose of Pinus nigraThomas Wieloch, Michael Grabner, Angela Augusti, et al.
Pageof 9